Related Experiment Video
Updated: Jun 26, 2026

12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Prospects for improved bluetongue vaccines
Polly Roy1, Mark Boyce, Robert Noad
1Department of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E7HT, UK. Polly.Roy@lshtm.ac.uk
Nature Reviews. Microbiology
|January 17, 2009
Summary
Bluetongue virus (BTV) is a significant livestock pathogen. This review explores advanced vaccine technologies to improve protection against BTV, addressing limitations of current options.
Area of Science:
- Veterinary Virology
- Vaccinology
- Animal Health
Background:
- Bluetongue virus (BTV) is an economically significant viral disease affecting livestock, particularly sheep.
- Recent BTV incursions in Europe have heightened the need for effective vaccines, especially for sensitive fine-wool sheep breeds.
- Existing BTV vaccines are effective but have limitations, driving research into improved alternatives.
Purpose of the Study:
- To review current leading vaccine technologies for bluetongue.
- To explore novel approaches for enhancing vaccine safety and broadening protection against BTV.
- To consider the application of advances in other viral vaccine development to BTV.
Main Methods:
- Literature review of bluetongue virus (BTV) and its serology.
- Analysis of existing and emerging vaccine manufacturing technologies.
- Exploration of cross-disciplinary advancements in viral vaccine research.
Main Results:
- The bluetongue virus and its serological responses are well-characterized.
- Vaccination is a proven method for preventing bluetongue disease.
- Several new technologies are under investigation to improve BTV vaccine efficacy and safety.
Conclusions:
- Improved bluetongue vaccines are crucial for mitigating economic losses in livestock.
- Ongoing research into novel vaccine platforms holds promise for enhanced BTV control.
- Leveraging advancements from other viral vaccine fields can accelerate progress in bluetongue vaccinology.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

